Third Harmonic Bio Inc (NASDAQ:THRD)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 2.67. At the close of trading, the stock’s price was $4.85, to imply a decrease of -5.27% or -$0.27 in intraday trading. The THRD share’s 52-week high remains $16.94, putting it -249.28% down since that peak but still an impressive 4.74% since price per share fell to its 52-week low of $4.62. The company has a valuation of $218.53M, with an average of 0.23 million shares in intraday trading volume over the past 10 days and average of 252.46K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Third Harmonic Bio Inc (THRD), translating to a mean rating of 1.60. Of 2 analyst(s) looking at the stock, 0 analyst(s) give THRD a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy.
Third Harmonic Bio Inc (NASDAQ:THRD) trade information
After registering a -5.27% downside in the last session, Third Harmonic Bio Inc (THRD) has traded red over the past five days. The 5-day price performance for the stock is -7.79%, and -55.75% over 30 days. With these gigs, the year-to-date price performance is -52.87%. Short interest in Third Harmonic Bio Inc (NASDAQ:THRD) saw shorts transact 3.52 million shares and set a 14.23 days time to cover.
The extremes give us $20 and $20 for target low and target high price respectively. As such, THRD has been trading -312.37% off suggested target high and -312.37% from its likely low.
THRD Dividends
Third Harmonic Bio Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Third Harmonic Bio Inc (NASDAQ:THRD)’s Major holders
Third Harmonic Bio Inc insiders hold 9.05% of total outstanding shares, with institutional holders owning 93.94% of the shares at 103.29% float percentage. In total, 93.94% institutions holds shares in the company, led by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC. As of 2024-06-30, the company held over 10.91 million shares (or 26.8961% of shares), all amounting to roughly $141.8 million.
The next major institution holding the largest number of shares is ORBIMED ADVISORS LLC with 5.78 million shares, or about 14.2498% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $75.13 million.
We also have Price (T.Rowe) Small-Cap Value Fund and Fidelity Select Portfolios – Health Care as the top two Mutual Funds with the largest holdings of the Third Harmonic Bio Inc (THRD) shares. Going by data provided on Sep 30, 2024 , Price (T.Rowe) Small-Cap Value Fund holds roughly 846.79 shares. This is just over 1.88% of the total shares, with a market valuation of $4.11 million. Data from the same date shows that the other fund manager holds a little less at 680.0, or 1.51% of the shares, all valued at about 3.3 million.
